124993-41-5

Upstream product

• 623-05-2 (4-hydroxyphenyl)methanol 
• 150235-40-8 [4-(quinolin-2-ylmethoxy)phenyl]methanol 

Downstream Products

• 141283-43-4 2-carboethoxy-5-hydroxy-3-(4-methoxyphenyl)-7-(4-(quinolin-2-ylmethoxy)benzyloxy)-4-oxo-4H-1-benzopyran 
• 124993-45-9 2-{4-[3-Methoxy-5-(1H-tetrazol-5-yl)-phenoxymethyl]-phenoxymethyl}-quinoline 
• 123225-96-7 5-[4-(4-(2-quinolinylmethyloxy)benzyloxy)-3-methoxyphenyl]tetrazole 
• 123225-60-5 5-[4-(4-(2-quinolinylmethyloxy)benzyloxy)phenyl]tetrazole 

Relevant academic research and scientific papers

PHENYLENE DERIVATIVES

This invention relates to a phenylene derivative represented by the following formula (1) or a salt thereof and also to a medicine containing it as an effective ingredient. STR1 wherein R 1 represents H or halogen; A represents--CH=CH--,--CH=N--,--N(R. su

N-benzyl dihydroindole LTD4 antagonists

This invention relates to pharmaceutical N-benzyl dihydroindole compounds having the general formula: STR1 and their use as LTD4 antagonists.

Pharmaceutical compounds

A compound having pharmaceutical activity, of the formula STR1 in which A is hydrogen or --(CR1 R2)x R3 where x is 0 or 1 to 4, R1 and R2 are each hydrogen or C1-4 alkyl and Rsu

Development of a Novel Series of (2-quinolinylmethoxy)phenyl-Containing Compounds as High-Affinity Leukotriene D4 Receptor Antagonists. 2. Effects of an Additional Phenyl Ring on Receptor Affinity

This series of reports describe the development of orally active, highly potent, specific antagonists of the peptidoleukotrienes containing a (2-quinolinylmethoxy)phenyl moiety.The compounds reported in this paper contain an additional phenyl ring, which